Potential of heparin and nafamostat combination therapy for COVID-19

J Thromb Haemost. 2020 Jun;18(6):1521-1522. doi: 10.1111/jth.14858. Epub 2020 May 6.

Authors

Hidesaku Asakura¹, Haruhiko Ogawa²

Affiliations

¹ Department of Hematology, Kanazawa University Hospital, Kanazawa, Japan.
² Department of Environmental and Preventive Medicine, Kanazawa University, Kanazawa, Japan.

No abstract available

Publication types

Letter
Comment

MeSH terms

Anticoagulants
Benzamidines
Betacoronavirus
COVID-19
Coronavirus Infections
Coronavirus*
Guanidines
Heparin*
Humans
Pandemics
Pneumonia, Viral
SARS-CoV-2

Substances

Anticoagulants
Benzamidines
Guanidines
Heparin
nafamostat